Literature DB >> 19874710

Anti-invasive activity of histone deacetylase inhibitors via the induction of Egr-1 and the modulation of tight junction-related proteins in human hepatocarcinoma cells.

Sung Ok Kim1, Byung Tae Choi, Il-Whan Choi, Jaehun Cheong, Gi-Young Kim, Taeg Kyu Kwon, Nam Deuk Kim, Yung Hyun Choi.   

Abstract

The potential anti-metastasis and anti-invasion activities of early growth response gene-1 (Egr-1) and claudin-3, a tight junction (TJ)-related protein, were evaluated using histone deacetylase (HDAC) inhibitors in human hepatocarcinoma cells. The results of wound healing and Transwell assays showed that HDAC inhibitors such as trichostatin A and sodium butyrate inhibited cell migration and invasion. HDAC inhibitors markedly induced Egr-1 expression during the early period, after which expression levels decreased. In addition, the down-regulation of snail and type 1 insulin-like growth factor receptor (IGF-1R) in HDAC inhibitor-treated cells induced the upregulation of thrombospondin-1 (TSP-1), E-cadherin and claudin-3. Cells transfected with Egr-1 and claudin-3 siRNA displayed significant blockage of HDAC inhibitor-induced anti-invasive activity. Collectively, these findings indicate that the up-regulation of Egr-1 and claudin-3 are crucial steps in HDAC inhibitor-induced anti-metastasis and anti-invasion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19874710     DOI: 10.5483/bmbrep.2009.42.10.655

Source DB:  PubMed          Journal:  BMB Rep        ISSN: 1976-6696            Impact factor:   4.778


  7 in total

1.  Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription.

Authors:  Hong-Bo Wang; Peng-Yuan Wang; Xin Wang; Yuan-Lian Wan; Yu-Cun Liu
Journal:  Dig Dis Sci       Date:  2012-06-09       Impact factor: 3.199

2.  Effects of a histone deacetylase inhibitor, sodium butyrate, on 53-kDa protein expression and sensitivity to anticancer drugs of pancreatic cancer cells.

Authors:  Masaki Kitazono; Hiroyuki Shinchi; Sumiya Ishigami; Shinichi Ueno; Shoji Natsugoe
Journal:  Curr Ther Res Clin Exp       Date:  2010-06

Review 3.  Histone deacetylases and mechanisms of regulation of gene expression.

Authors:  Hong Ping Chen; Yu Tina Zhao; Ting C Zhao
Journal:  Crit Rev Oncog       Date:  2015

4.  Podocyte histone deacetylase activity regulates murine and human glomerular diseases.

Authors:  Kazunori Inoue; Geliang Gan; Maria Ciarleglio; Yan Zhang; Xuefei Tian; Christopher E Pedigo; Corey Cavanaugh; Janet Tate; Ying Wang; Elizabeth Cross; Marwin Groener; Nathan Chai; Zhen Wang; Amy Justice; Zhenhai Zhang; Chirag R Parikh; Francis P Wilson; Shuta Ishibe
Journal:  J Clin Invest       Date:  2019-02-18       Impact factor: 14.808

5.  LCZ696 Possesses a Protective Effect Against Homocysteine (Hcy)-Induced Impairment of Blood-Brain Barrier (BBB) Integrity by Increasing Occludin, Mediated by the Inhibition of Egr-1.

Authors:  Wenfeng Li; Wenjin Yuan; Dandan Zhang; Shuchun Cai; Jun Luo; Kanghua Zeng
Journal:  Neurotox Res       Date:  2021-09-20       Impact factor: 3.911

Review 6.  Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers.

Authors:  Masumeh Sanaei; Fraidoon Kavoosi
Journal:  Adv Biomed Res       Date:  2019-10-31

7.  Gene Ontology and Expression Studies of Strigolactone Analogues on a Hepatocellular Carcinoma Cell Line.

Authors:  Mohammed Nihal Hasan; Syed Shoeb Razvi; Hani Choudhry; Mohammed A Hassan; Said Salama Moselhy; Taha Abduallah Kumosani; Mazin A Zamzami; Khalid Omer Abualnaja; Majed A Halwani; Abdulrahman Labeed Al-Malki; Jiannis Ragoussis; Wei Wu; Christian Bronner; Tadao Asami; Mahmoud Alhosin
Journal:  Anal Cell Pathol (Amst)       Date:  2019-08-04       Impact factor: 2.916

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.